Biomaterial‐Based Therapeutic Delivery of Immune Cells
2025

Biomaterial-Based Therapeutic Delivery of Immune Cells

publication Evidence: moderate

Author Information

Author(s): Dravid Ameya A., Singh Ankur, García Andrés J.

Primary Institution: Georgia Institute of Technology

Hypothesis

Can biomaterial-assisted delivery of immune cells improve their therapeutic potential and reduce associated toxicities?

Conclusion

Biomaterial-assisted delivery of immune cells can enhance localization, reduce toxicity, and maintain desired cell phenotypes, improving therapeutic outcomes.

Supporting Evidence

  • Biomaterials can improve the localization of immune cells at disease sites.
  • Hydrogels can help maintain the activated state of immune cells.
  • Engineered carriers can reduce the toxicity associated with immune cell therapies.
  • Recent studies show improved outcomes in vivo with biomaterial-assisted delivery.
  • Biomaterials can co-deliver cytokines to enhance immune cell function.

Takeaway

This study shows that using special materials to deliver immune cells can help them work better and cause fewer side effects.

Methodology

The review discusses various biomaterial-based strategies for delivering immune cells and their impact on treatment efficacy.

Limitations

The review highlights that many studies are preclinical and may not translate directly to human applications.

Digital Object Identifier (DOI)

10.1002/adhm.202400586

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication